Patient Monitoring & Vital Signs in California

Belun Technology designs and manufactures medical-grade wearable devices and AI-powered software platforms for sleep health monitoring, home sleep apnea testing, and remote patient vital signs monitoring. The company's core offerings include the Belun® Ring, an FDA 510(k)-cleared wearable device that performs home sleep apnea screening and monitors sleep health using clinically validated algorithms, and the Belun® remoVital system, a real-time remote vital signs monitoring solution comprising the Belun® Ring, Belun® COR (body temperature sensor), and a communication hub. The remoVital system measures blood oxygen saturation, pulse rate, and body temperature, with alert functionality designed to enable early detection of clinical deterioration and support timely medical intervention. Products target both consumers seeking self-managed wellness monitoring and healthcare professionals requiring scalable remote monitoring solutions for clinical accuracy and care quality improvement. The company emphasizes medical-grade accuracy, ease of use, and affordability. Belun holds FDA 510(k) clearance for its sleep monitoring and vital signs monitoring systems. The platform employs proprietary AI algorithms for predictive analytics and personalized care delivery. Markets served include home-based sleep apnea screening, remote patient monitoring in residential care facilities, and integrated telehealth/remote care workflows. The company has received strategic investment from IHH Healthcare and Gravity Capital Partners, indicating growth in global expansion and product development.

Acro Biotech, Inc. is a medical diagnostics manufacturer based in Montclair, California, specializing in point-of-care and clinical laboratory testing solutions. The company develops and distributes a diverse portfolio of diagnostic analyzers and rapid testing systems across multiple therapeutic and clinical domains. Product lines include respiratory infection rapid tests (COVID-19 and other respiratory panels, though COVID tests are not FDA-cleared for US distribution), drugs of abuse screening tests, cardiac biomarker assays, urine analyzers, fluorescence immunoassay analyzers, and multiparameter handheld meters for hemoglobin, cholesterol, uric acid, and glucose testing. The company also offers solutions for women's health, infectious disease serology, tumor markers, and veterinary diagnostics. Key analyzer platforms include the ATR-ACO300 urine analyzer, AFR-600 fluorescence immunoassay system (Apoti), AHR-100 multiparameter meter for hemoglobin/cholesterol/uric acid/glucose, and LF Reader systems. The company serves clinical laboratories, point-of-care testing facilities, and veterinary markets with rapid testing and automated laboratory equipment. No specific FDA 510(k) clearances, ISO certifications, or CE Mark designations are stated on the website. Manufacturing capabilities and regulatory status for products marketed outside the US are not detailed in available content.

seca is a global manufacturer of medical measurement and body composition analysis systems for healthcare, wellness, and fitness markets. The company designs and distributes precision scales, height measurement devices, and bioimpedance analysis (BIA) systems for patient measurement and monitoring in clinical, hospital, and home settings. Product lines include the seca 777 series (modular measuring stations), seca XLine (advanced patient measurement platform), seca mBCA series (medical body composition analyzers including mBCA Alpha, mBCA Ultra, mBCA Go, and mBCA variants 514 and 525), and the seca TRU Alpha (fitness and medical body composition system). The company also offers the seca 284 and 286 EMR-ready measuring stations with integrated digital height rods and optional wireless transmission. seca manufactures mechanical and digital scales (models 700, 755), mobile measuring mats (seca 210), and baby scales (seca 334, seca 374) for pediatric and neonatal applications. Devices support cloud-based data management and EMR integration. seca holds MDR (Medical Device Regulation) certification since 2020, indicating compliance with EU medical device standards. The company serves hospitals, clinics, physician offices, wellness centers, and fitness facilities. Manufacturing capabilities include digital connectivity, voice guidance systems, and rechargeable battery options for portable configurations.

Dexcom, Inc. is a leader in continuous glucose monitoring (CGM) systems and glucose biosensing technology, founded in 1999 and headquartered in San Diego, California. The company develops real-time glucose sensing devices that transmit glucose readings directly to smartphones and receivers, enabling people with diabetes to monitor their blood glucose levels continuously and make informed treatment decisions. Dexcom's primary product line includes the Dexcom G7 CGM System and the Dexcom G7 15 Day sensor, designed for adults 18+ with all types of diabetes. The G7 offers best-in-class accuracy and an extended 15-day wear period, with approximately 74% of sensors lasting the full duration. The company also offers Stelo Glucose Biosensor, an over-the-counter (OTC) integrated CGM intended for people 18+ not on insulin, including those with prediabetes or seeking general wellness optimization. Stelo requires no prescription, no fingersticks, and delivers personal glucose insights to users' phones. Dexcom's ecosystem includes connectivity with multiple smart devices and partner integrations to reduce the burden of diabetes management. The company serves patients across multiple insurance channels including commercial, Medicare Advantage, Medicare, Medicaid, VA Health Care, and Kaiser, as well as uninsured/cash-pay patients. Dexcom maintains FDA 510(k) clearance and regulatory compliance for its medical devices and supports healthcare providers through a dedicated provider portal. Manufacturing and distribution capabilities include pharmacy and medical supplier channels.

Evergreen International Group (EIG) is a California-based medical supply distributor serving skilled nursing facilities (SNFs) and healthcare providers across the state. Founded as a small West Los Angeles operation serving Eva Care Groups' facilities, EIG has expanded to serve over 300 facilities with distribution centers in Hayward and Monterey Park. The company specializes in infection control consumables, personal protective equipment (PPE), cleaning and disinfection products, first aid supplies, and medical apparel. Product offerings include disposable face masks (earloop and cloth varieties), examination gloves (vinyl), isolation gowns with ties, infrared thermometers, and commercial-grade disinfectants such as Clorox solutions. EIG operates a B2B e-commerce platform (eigshop.com) serving institutional customers with pricing, bulk ordering, and warehousing capabilities. The company emphasizes localized, personalized customer service with regional availability and free shipping on orders exceeding $50 within California. Operations span Monday–Friday business hours across head office and warehouse locations. EIG's market focus remains the skilled nursing home sector within California, though the online platform enables broader institutional reach.

i-SENS is a global biotechnology company headquartered in South Korea and operating in over 110 countries, including the United States and Europe. The company is the market leader in Korea's blood glucose monitoring device market and specializes in blood glucose management systems, continuous glucose monitoring (CGM) systems, in vitro diagnostics (IVD), and veterinary diagnostic solutions. i-SENS manufactures the CareSens line of self-monitoring blood glucose systems, which meets ISO 15197:2013 accuracy standards for hematocrit and interference criteria. The CareSens Air continuous glucose monitoring system is the first domestically produced CGM in Korea with CE certification, providing real-time glucose data and trend analysis for diabetes management. The company's IVD System leverages whole blood-based diagnostic technology for point-of-care testing applications. i-SENS operates with an annual production capacity of 2.1 billion blood glucose test strips, supporting millions of patients globally. The company maintains regulatory compliance with FDA and CE certification standards. Recent partnerships include a transformational collaboration with LifeScan to launch the OneTouch® Continuous Glucose Monitoring System, leveraging i-SENS technology. The company serves healthcare systems, diabetes management clinics, point-of-care diagnostic facilities, and veterinary care providers. i-SENS is committed to advancing diabetes care innovation and expanding access to glucose monitoring solutions worldwide.

Silex Global LLC is a healthcare and household products provider founded in 2014, operating across the United States, Canada, Mexico, and Europe. The company markets medical devices and wellness products under its Paramed brand, which specializes in both professional and domestic healthcare applications. Paramed's primary product lines include automatic and mechanical blood pressure monitors, digital and analog thermometers, and stethoscopes. All Paramed products are FDA-approved, CE-certified, and meet ISO standards. The company reports annual sales exceeding 100,000 blood pressure monitors, 10,000 thermometers, and 20,000 stethoscopes, serving more than 50,000 customers. Silex Global positions itself as a B2B supplier targeting distribution and retail companies seeking long-term partnerships. Products are designed for ease of use, portability, and advanced functionality, with independent testing and quality assurance prior to market release. The company emphasizes customer-centric service, rapid response times, and responsibility for product quality as core business values.

NeurOptics is a worldwide leader in pupillometry technology for critical care, neurology, neurosurgery, emergency medicine, and applied research. The company develops and markets the NPi-300 Pupillometer, a handheld device that provides objective, quantitative assessment of pupil size and reactivity independent of examiner variability. The NPi-300 is adopted in over 1,000 U.S. hospitals and represented in more than 50 countries globally. The device measures pupillary responses and constriction velocity, enabling clinicians to detect subtle changes in pupillary response that may indicate increased intracranial pressure, neurological decline, or brain injury—particularly valuable in sedated or comatose patients where subjective penlight examination is unreliable. NeurOptics also provides pupillometry instrumentation for applied research applications, supporting both human and animal research across various clinical and research settings. The company emphasizes device integration with electronic medical records (EMR) to streamline clinical workflows and enable trend analysis of pupillary data as a vital sign. The NPi-300 is used extensively in neurocritical care units, stroke services, trauma centers, and cardiac arrest care settings. Clinical evidence supports the device in management of traumatic brain injury, cardiac arrest, malignant cerebral edema, and assessment for brain death determination.

Zepp Health is a consumer health technology company delivering smart wearable healthcare solutions and digital health management platforms. The company manufactures intelligent wearables including smartwatches, smart bands, and smart hearing devices capable of continuous 24/7 health monitoring and biometric data collection. The Zepp Digital Health Management Platform integrates proprietary Zepp OS, AI chips, biometric sensors, and data algorithms to provide cloud-based actionable health insights and personalized wellness guidance. Key capabilities include real-time physiological monitoring, AI-driven sports and sleep coaching, atrial fibrillation detection (with 135,000+ suspected AFib events detected), and generative AI solutions utilizing Large Language Models for natural language interaction. The platform delivers preventative care insights and enables users to understand their health data for informed decision-making. Zepp Health serves a global consumer market with 42+ million active users across 90+ countries and has shipped over 200 million units worldwide. The company collaborates with 25+ world-class research partners and combines audiologist expertise with wearable technology for hearing solutions. Products feature proprietary sensors and algorithms optimized for continuous health tracking, fitness monitoring, sleep analysis, and wellness optimization across consumer segments.

AccuVein is a medical device manufacturer specializing in near-infrared (NIR) vein visualization technology for vascular access procedures. The company develops handheld vein finder devices that enable healthcare professionals to visualize peripheral veins, valves, and bifurcations not visible to the naked eye, improving peripheral IV catheter placement success rates and reducing procedure time and complications. AccuVein's primary products serve acute care settings (emergency departments, ICUs, general wards), non-acute care environments (outpatient clinics, home care), and aesthetic/cosmetic medicine practices. Clinical evidence supports the technology with 92% first-attempt success rates for IV placement, 78% reduction in procedure time, 45% decrease in escalation calls, and 39% reduction in patient pain. The company manufactures multiple generations of vein visualization devices, including the AV500, AV600 (fourth-generation model recently launched), and associated accessories such as the HF580 Powered Stand for hands-free mobile applications. AccuVein's devices are recommended by leading professional societies for pre-insertion vascular assessment and are positioned to improve clinical outcomes, operational efficiency, staff well-being, and healthcare equity by enabling successful venous access across diverse patient populations.

Thermomedics, Inc. manufactures the CAREGIVER® Clinical Grade Non-Contact Infrared Thermometer (NCIT), a non-contact forehead thermometer developed by the team that invented tympanic thermometry. Introduced over 13 years ago, the CAREGIVER® has become the primary offering for hospitals, clinics, schools, and first-responder/rescue situations for measurement of forehead temperature in adults, children, and infants. The device delivers measurement results in 1–2 seconds with documented clinical precision and operates with AA battery power sufficient for up to 15,000 temperature measurements. Key features include non-contact infrared technology that eliminates probe covers and cross-contamination risk, bright backlit display with 30-temperature memory recall, one-button operation, and multi-task capability to measure room temperature and skin/surface temperature. The thermometer is rugged for routine hospital/clinical handling and is offered through major GPOs, IDNs, and supply chain leaders including VIZIENT, HPG, KAISER, NDC, McKesson, KentecAmerican, and a national network of regional healthcare dealers. Accessory offerings include wall-mount models, calibration verification systems, and secure tether models. The company supports clinical professionals with industry-leading customer service, product registration, and a comprehensive system of optional accessories for hospital/clinical management of efficient, safe, and accurate vital signs measurement.

ACON Laboratories, Inc. is a US FDA-registered global medical device manufacturer specializing in point-of-care testing (POCT) and immunoassay products. Headquartered in San Diego, California, the company develops and manufactures diagnostic solutions across four primary product lines: Point of Care, Immunoassays, Molecular Diagnostics, and Animal Health. Products serve hospitals, clinical laboratories, physician offices, blood banks, pharmacies, and veterinary clinics worldwide. The On Call® Blood Glucose Meter Family is designed for glucose monitoring and diabetes management. Mission® brand includes urine reagent test strips, urine analyzers, and handheld devices for cholesterol, coagulation, and hemoglobin measurement. HealthyMe® provides urinary tract infection (UTI) detection reagent strips. Flow flex® is the newest lateral flow rapid testing brand, offering multiplexed home tests including the recently FDA 510(k)-cleared Flow flex® Plus RSV + Flu A/B + COVID multiplex rapid antigen test for ages 6 months and up. The company's ACON brand offers lateral flow rapid tests for pregnancy, cancer markers, and infectious disease screening, including SARS-CoV-2 antibody and antigen tests. Distinct® provides pregnancy rapid tests using qualitative chromatographic immunoassays. Foresight® offers allergen immunoblot testing for 30 allergens on a single strip. Promotor® provides nucleic acid extraction systems and PCR quantitative test kits for HBV, HCV, HPV 16/18, HPV genotyping, tuberculosis, and HLA-B27. CentriVet® serves veterinary diagnostics with dual ketone/glucose meters and urine reagent strips. ACON maintains US FDA registration, provides contract manufacturing and OEM services, and holds multiple FDA 510(k) clearances for its diagnostic products.